Skip to main navigation Skip to search Skip to main content

Effect of TNP-470 (AGM-1470) on the growth of rat rhabdomyosarcoma tumors of different sizes

  • W Landuyt*
  • , J Theys
  • , S Nuyts
  • , M Drijkoningen
  • , J Fowler
  • , A Reijnders
  • , S Liekens
  • , J Neyts
  • , E de Bruijn
  • , J Anne
  • , P Lambin
  • *Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

47 Downloads (Pure)

Abstract

Potential anticancer therapy with the fumagillin analog TNP-470 was investigated in the present project using subcutaneously growing rhabdomyosarcomas in rats. Specifically, influences of different tumor sizes at the start of treatment as well as dose/schedules were evaluated with this angiogenesis inhibitor The results show a significant (p = less than or equal to0.01) reduction of the growth rare, even for relatively large-sized (>7 cm(3)) tumors, when 50 m/kg TNP-470 was used every other day for up to 3 or 5 injections. With 30 mg/kg TNP-470 injections, effects were seen only with tumors measuring

Original languageEnglish
Pages (from-to)35-40
Number of pages6
JournalCancer Investigation
Volume19
Issue number1
DOIs
Publication statusPublished - 2001
Externally publishedYes

Keywords

  • ANGIOGENESIS INHIBITOR
  • METASTASIS
  • FUMAGILLIN
  • CANCER

Fingerprint

Dive into the research topics of 'Effect of TNP-470 (AGM-1470) on the growth of rat rhabdomyosarcoma tumors of different sizes'. Together they form a unique fingerprint.

Cite this